Budget Amount *help |
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2016: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2015: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2014: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
Outline of Final Research Achievements |
In this study, to identify tumor endothelial marker (TEC marker) that is involved in drug resistance, drug sensitivity to anti-cancer drug was analyzed using siRNA or inhibitor of TEC markers. The inhibitor of p-glycoprotein encoded by MDR-1 gene, enhanced sensitivity to paclitaxel, in vitro and in vivo. These results suggested that inhibition of TEC markers are possible strategy to overcome drug resistance.
|